However, a significant difference between MM patients and healthy individuals has been observed, with approximately a 50% reduction in myeloid DCs (BDCA1+) and pDCs (BDCA2+) in the peripheral blood (PB) of MM patients [20,21,101]. This evidence concerns the gene CD1C and Miyoshi myopathy.